Osteoarthritis Trial, Recruiting NCT07695168 Sponsor: National Taiwan University Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07695168
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group A – Healthy Adults:

  • People between 20 and 80 years of age
  • People who have no knee discomfort, such as knee pain or muscle weakness

Group B – People with Knee Osteoarthritis:

  • People between 50 and 80 years of age
  • People who have been diagnosed with knee osteoarthritis, rated as a mild to moderate level of severity on a standard medical scale (Kellgren-Lawrence grade 1 to 3)

Who may not be able to join:

  • People who have had surgery on a knee or hip in the past
  • People with a form of arthritis that affects the whole body (such as rheumatoid arthritis)
  • People with a neurological (nervous system) disease
  • People with a current or past diagnosis of cancer
  • People with an untreated bone infection, or whose bones are still developing (confirm with trial site)
  • People who are pregnant
  • People with inflammatory ulcers
  • People with deep vein thrombosis (a blood clot in a deep vein)
  • People with wounds that are excessively wet or moist
  • People with hemophilia (a condition where blood does not clot properly)
  • People with an active infection in the area being treated or assessed
  • People who have recently had a heart attack
  • People with unstable angina (unpredictable chest pain related to the heart)
  • People with severe narrowing of the aortic heart valve
  • People with heart failure that is not well controlled
  • People with an acute (sudden) blood clot in the lungs
  • People with sudden inflammation of the heart muscle or the sac surrounding the heart
  • People with an acute tear in the wall of the main artery from the heart

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-2-3366-8127

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Pain Visual Analog Scale; Western Ontario and McMaster Universities Osteoarthritis Index; Electromyographic Muscle Activity; Biomechanical Motion Analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov